<DOC>
	<DOCNO>NCT02271347</DOCNO>
	<brief_summary>The purpose study assess safety tolerability Brincidofovir ( BCV ) administer initial 200mg dose follow 100mg twice weekly ( BIW ) total 5 dos .</brief_summary>
	<brief_title>An Open-Label , Multicenter Study Safety Anti Viral Activity Brincidofovir ( BCV , CMX001 ) Ebola Virus Disease</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Hemorrhagic Fever , Ebola</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>Positive Ebola virus RNA plasma Subject must able ingest , absorb , tolerate oral medication Subject must willing use adequate contraception participation</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>